View More View Less
  • 1 Medical University of Graz Research Unit of Translational Neurogastroenterology, Institute of Experimental and Clinical Pharmacology Universitätsplatz 4 8010 Graz Austria
Open access

With microbiome research being a fiercely contested playground in science, new data are being published at tremendous pace. The review at hand serves to critically revise four microbial metabolites widely applied in research: butyric acid, flagellin, lipoteichoic acid, and propionic acid. All four metabolites are physiologically present in healthy humans. Nevertheless, all four are likewise involved in pathologies ranging from cancer to mental retardation. Their inflammatory potential is equally friend and foe. The authors systematically analyze positive and negative attributes of the aforementioned substances, indicating chances and dangers with the use of pre- and probiotic therapeutics. Furthermore, the widespread actions of microbial metabolites on distinct organs and diseases are reconciled. Moreover, the review serves as critical discourse on scientific methods commonly employed in microbiome research and comparability as well as reproducibility issues arising thereof.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • Pappas G, Kiriaze IJ, Falagas ME: Insights into infectious disease in the era of Hippocrates. Int J Infect Dis 12, 347–350 (2008)

    Falagas ME , 'Insights into infectious disease in the era of Hippocrates ' (2008 ) 12 Int J Infect Dis : 347 -350.

    • Search Google Scholar
  • Hach W: Puerperal sepsis in the 19th century and Trendlenburg’s ligature of the internal iliacal vein. Hamostaseologie 27, 111–116 (2007)

    Hach W , 'Puerperal sepsis in the 19th century and Trendlenburg’s ligature of the internal iliacal vein ' (2007 ) 27 Hamostaseologie : 111 -116.

    • Search Google Scholar
  • Pasteur L, Chamberland, Roux: Summary report of the experiments conducted at Pouilly-le-Fort, near Melun, on the anthrax vaccination, 1881. Yale J Biol Med 75, 59–62 (2002)

    Chamberland R , 'Summary report of the experiments conducted at Pouilly-le-Fort, near Melun, on the anthrax vaccination, 1881 ' (2002 ) 75 Yale J Biol Med : 59 -62.

    • Search Google Scholar
  • Wennergren G, Lagercrantz H: “One sometimes finds what one is not looking for” (Sir Alexander Fleming): the most important medical discovery of the 20th century. Acta Paediatr 96, 141–144 (2007)

    Lagercrantz H , '“One sometimes finds what one is not looking for” (Sir Alexander Fleming): the most important medical discovery of the 20th century ' (2007 ) 96 Acta Paediatr : 141 -144.

    • Search Google Scholar
  • Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto JM, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Li S, Jian M, Zhou Y, Li Y, Zhang X, Li S, Qin N, Yang H, Wang J, Brunak S, Dore J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J, MetaHIT Consortium, Bork P, Ehrlich SD, Wang J: A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59–65 (2010)

    Weissenbach J , 'A human gut microbial gene catalogue established by metagenomic sequencing ' (2010 ) 464 Nature : 59 -65.

    • Search Google Scholar
  • Schloissnig S, Arumugam M, Sunagawa S, Mitreva M, Tap J, Zhu A, Waller A, Mende DR, Kultima JR, Martin J, Kota K, Sunyaev SR, Weinstock GM, Bork P: Genomic variation landscape of the human gut microbiome. Nature 493, 45–50 (2013)

    Bork P , 'Genomic variation landscape of the human gut microbiome ' (2013 ) 493 Nature : 45 -50.

    • Search Google Scholar
  • Guarner F, Malagelada JR: Gut flora in health and disease. Lancet 361, 512–519 (2003)

    Malagelada JR , 'Gut flora in health and disease ' (2003 ) 361 Lancet : 512 -519.

  • Quigley EM: Gut bacteria in health and disease. Gastroenterol Hepatol (N Y) 9, 560–569 (2013)

    Quigley EM , 'Gut bacteria in health and disease ' (2013 ) 9 Gastroenterol Hepatol (N Y) : 560 -569.

    • Search Google Scholar
  • Huang XZ, Zhu LB, Li ZR, Lin J: Bacterial colonization and intestinal mucosal barrier development. World J Clin Pediatr 2, 46–53 (2013)

    Lin J , 'Bacterial colonization and intestinal mucosal barrier development ' (2013 ) 2 World J Clin Pediatr : 46 -53.

    • Search Google Scholar
  • Ferreira CM, Vieira AT, Vinolo MA, Oliveira FA, Curi R, Martins FD: The central role of the gut microbiota in chronic inflammatory diseases. J Immunol Res 2014, 689492 (2014)

    Martins FD , 'The central role of the gut microbiota in chronic inflammatory diseases ' (2014 ) 2014 J Immunol Res : 689492 -.

    • Search Google Scholar
  • Diaz Heijtz R, Wang S, Anuar F, Qian Y, Bjorkholm B, Samuelsson A, Hibberd ML, Forssberg H, Pettersson S: Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A 108, 3047–3052 (2011)

    Pettersson S , 'Normal gut microbiota modulates brain development and behavior ' (2011 ) 108 Proc Natl Acad Sci U S A : 3047 -3052.

    • Search Google Scholar
  • Dinan TG, Stanton C, Cryan JF: Psychobiotics: a novel class of psychotropic. Biol Psychiatry 74, 720–726 (2013)

    Cryan JF , 'Psychobiotics: a novel class of psychotropic ' (2013 ) 74 Biol Psychiatry : 720 -726.

    • Search Google Scholar
  • Desbonnet L, Garrett L, Clarke G, Bienenstock J, Dinan TG: The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat. J Psychiatr Res 43, 164–174 (2008)

    Dinan TG , 'The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat ' (2008 ) 43 J Psychiatr Res : 164 -174.

    • Search Google Scholar
  • Desbonnet L, Garrett L, Clarke G, Kiely B, Cryan JF, Dinan TG: Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 170, 1179–1188 (2010)

    Dinan TG , 'Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression ' (2010 ) 170 Neuroscience : 1179 -1188.

    • Search Google Scholar
  • Bienenstock J, Collins S: 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: psycho-neuroimmunology and the intestinal microbiota: clinical observations and basic mechanisms. Clin Exp Immunol 160, 85–91 (2010)

    Collins S , '99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: psycho-neuroimmunology and the intestinal microbiota: clinical observations and basic mechanisms ' (2010 ) 160 Clin Exp Immunol : 85 -91.

    • Search Google Scholar
  • Sanz Y, Nadal I, Sanchez E: Probiotics as drugs against human gastrointestinal infections. Recent Pat Antiinfect Drug Discov 2, 148–156 (2007)

    Sanchez E , 'Probiotics as drugs against human gastrointestinal infections ' (2007 ) 2 Recent Pat Antiinfect Drug Discov : 148 -156.

    • Search Google Scholar
  • Nyangale EP, Mottram DS, Gibson GR: Gut microbial activity, implications for health and disease: the potential role of metabolite analysis. J Proteome Res 11, 5573–5585 (2012)

    Gibson GR , 'Gut microbial activity, implications for health and disease: the potential role of metabolite analysis ' (2012 ) 11 J Proteome Res : 5573 -5585.

    • Search Google Scholar
  • Russell WR, Hoyles L, Flint HJ, Dumas ME: Colonic bacterial metabolites and human health. Curr Opin Microbiol 16, 246–254 (2013)

    Dumas ME , 'Colonic bacterial metabolites and human health ' (2013 ) 16 Curr Opin Microbiol : 246 -254.

    • Search Google Scholar
  • Joyce SA, Gahan CG: The gut microbiota and the metabolic health of the host. Curr Opin Gastroenterol 30, 120–127 (2014)

    Gahan CG , 'The gut microbiota and the metabolic health of the host ' (2014 ) 30 Curr Opin Gastroenterol : 120 -127.

    • Search Google Scholar
  • Song WS, Yoon SI: Crystal structure of FliC flagellin from Pseudomonas aeruginosa and its implication in TLR5 binding and formation of the flagellar filament. Biochem Biophys Res Commun 444, 109–115 (2014)

    Yoon SI , 'Crystal structure of FliC flagellin from Pseudomonas aeruginosa and its implication in TLR5 binding and formation of the flagellar filament ' (2014 ) 444 Biochem Biophys Res Commun : 109 -115.

    • Search Google Scholar
  • Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, Eng JK, Akira S, Underhill DM, Aderem A: The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410, 1099–1103 (2001)

    Aderem A , 'The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 ' (2001 ) 410 Nature : 1099 -1103.

    • Search Google Scholar
  • Aldridge P, Hughes KT: Regulation of flagellar assembly. Curr Opin Microbiol 5, 160–165 (2002)

    Hughes KT , 'Regulation of flagellar assembly ' (2002 ) 5 Curr Opin Microbiol : 160 -165.

  • Jacchieri SG, Torquato R, Brentani RR: Structural study of binding of flagellin by Toll-like receptor 5. J Bacteriol 185, 4243–4247 (2003)

    Brentani RR , 'Structural study of binding of flagellin by Toll-like receptor 5 ' (2003 ) 185 J Bacteriol : 4243 -4247.

    • Search Google Scholar
  • Smith KD, Andersen-Nissen E, Hayashi F, Strobe K, Bergman MA, Barrett SL, Cookson BT, Aderem A: Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat Immunol 4, 1247–1253 (2003)

    Aderem A , 'Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility ' (2003 ) 4 Nat Immunol : 1247 -1253.

    • Search Google Scholar
  • Murthy KG, Deb A, Goonesekera S, Szabo C, Salzman AL: Identification of conserved domains in Salmonella muenchen flagellin that are essential for its ability to activate TLR5 and to induce an inflammatory response in vitro. J Biol Chem 279, 5667–5675 (2004)

    Salzman AL , 'Identification of conserved domains in Salmonella muenchen flagellin that are essential for its ability to activate TLR5 and to induce an inflammatory response in vitro ' (2004 ) 279 J Biol Chem : 5667 -5675.

    • Search Google Scholar
  • Zhang L, Pan Z, Kang X, Yang Y, Kang H, Zhang N, Rosati JM, Jiao X: Amino acids 89–96 of Salmonella typhimurium flagellin represent the major domain responsible for TLR5-independent adjuvanticity in the humoral immune response. Cell Mol Immunol (2014)

    Jiao X , '', in Cell Mol Immunol , (2014 ) -.

  • Means TK, Hayashi F, Smith KD, Aderem A, Luster AD: The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells. J Immunol 170, 5165–5175 (2003)

    Luster AD , 'The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells ' (2003 ) 170 J Immunol : 5165 -5175.

    • Search Google Scholar
  • Zeng H, Wu H, Sloane V, Jones R, Yu Y, Lin P, Gewirtz AT, Neish AS: Flagellin/TLR5 responses in epithelia reveal intertwined activation of inflammatory and apoptotic pathways. Am J Physiol Gastrointest Liver Physiol 290, G96–G108 (2006)

    Neish AS , 'Flagellin/TLR5 responses in epithelia reveal intertwined activation of inflammatory and apoptotic pathways ' (2006 ) 290 Am J Physiol Gastrointest Liver Physiol : G96 -G108.

    • Search Google Scholar
  • Zhang Z, Louboutin JP, Weiner DJ, Goldberg JB, Wilson JM: Human airway epithelial cells sense Pseudomonas aeruginosa infection via recognition of flagellin by Tolllike receptor 5. Infect Immun 73, 7151–7160 (2005)

    Wilson JM , 'Human airway epithelial cells sense Pseudomonas aeruginosa infection via recognition of flagellin by Tolllike receptor 5 ' (2005 ) 73 Infect Immun : 7151 -7160.

    • Search Google Scholar
  • Ortega-Cava CF, Ishihara S, Rumi MA, Aziz MM, Kazumori H, Yuki T, Mishima Y, Moriyama I, Kadota C, Oshima N, Amano Y, Kadowaki Y, Ishimura N, Kinoshita Y: Epithelial toll-like receptor 5 is constitutively localized in the mouse cecum and exhibits distinctive down-regulation during experimental colitis. Clin Vaccine Immunol 13, 132–138 (2006)

    Kinoshita Y , 'Epithelial toll-like receptor 5 is constitutively localized in the mouse cecum and exhibits distinctive down-regulation during experimental colitis ' (2006 ) 13 Clin Vaccine Immunol : 132 -138.

    • Search Google Scholar
  • Gewirtz AT, Simon PO, Jr, Schmitt CK, Taylor LJ, Hagedorn CH, O’Brien AD, Neish AS, Madara JL: Salmonella typhimurium translocates flagellin across intestinal epithelia, inducing a proinflammatory response. J Clin Invest 107, 99–109 (2001)

    Madara JL , 'Salmonella typhimurium translocates flagellin across intestinal epithelia, inducing a proinflammatory response ' (2001 ) 107 J Clin Invest : 99 -109.

    • Search Google Scholar
  • Gewirtz AT, Yu Y, Krishna US, Israel DA, Lyons SL, Peek RM, Jr: Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity. J Infect Dis 189, 1914–1920 (2004)

    Peek RM , 'Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity ' (2004 ) 189 J Infect Dis : 1914 -1920.

    • Search Google Scholar
  • Johanesen PA, Dwinell MB: Flagellin-independent regulation of chemokine host defense in Campylobacter jejuni-infected intestinal epithelium. Infect Immun 74, 3437–3447 (2006)

    Dwinell MB , 'Flagellin-independent regulation of chemokine host defense in Campylobacter jejuni-infected intestinal epithelium ' (2006 ) 74 Infect Immun : 3437 -3447.

    • Search Google Scholar
  • Andersen-Nissen E, Smith KD, Strobe KL, Barrett SL, Cookson BT, Logan SM, Aderem A: Evasion of Toll-like receptor 5 by flagellated bacteria. Proc Natl Acad Sci U S A 102, 9247–9252 (2005)

    Aderem A , 'Evasion of Toll-like receptor 5 by flagellated bacteria ' (2005 ) 102 Proc Natl Acad Sci U S A : 9247 -9252.

    • Search Google Scholar
  • Franchi L, Amer A, Body-Malapel M, Kanneganti TD, Ozoren N, Jagirdar R, Inohara N, Vandenabeele P, Bertin J, Coyle A, Grant EP, Nunez G: Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat Immunol 7, 576–582 (2006)

    Nunez G , 'Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages ' (2006 ) 7 Nat Immunol : 576 -582.

    • Search Google Scholar
  • Miao EA, Alpuche-Aranda CM, Dors M, Clark AE, Bader MW, Miller SI, Aderem A: Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat Immunol 7, 569–575 (2006)

    Aderem A , 'Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf ' (2006 ) 7 Nat Immunol : 569 -575.

    • Search Google Scholar
  • Wright EK, Goodart SA, Growney JD, Hadinoto V, Endrizzi MG, Long EM, Sadigh K, Abney AL, Bernstein-Hanley I, Dietrich WF: Naip5 affects host susceptibility to the intracellular pathogen Legionella pneumophila. Curr Biol 13, 27–36 (2003)

    Dietrich WF , 'Naip5 affects host susceptibility to the intracellular pathogen Legionella pneumophila ' (2003 ) 13 Curr Biol : 27 -36.

    • Search Google Scholar
  • Molofsky AB, Byrne BG, Whitfield NN, Madigan CA, Fuse ET, Tateda K, Swanson MS: Cytosolic recognition of flagellin by mouse macrophages restricts Legionella pneumophila infection. J Exp Med 203, 1093–1104 (2006)

    Swanson MS , 'Cytosolic recognition of flagellin by mouse macrophages restricts Legionella pneumophila infection ' (2006 ) 203 J Exp Med : 1093 -1104.

    • Search Google Scholar
  • Lightfield KL, Persson J, Brubaker SW, Witte CE, von Moltke J, Dunipace EA, Henry T, Sun YH, Cado D, Dietrich WF, Monack DM, Tsolis RM, Vance RE: Critical function for Naip5 in inflammasome activation by a conserved carboxy-terminal domain of flagellin. Nat Immunol 9, 1171–1178 (2008)

    Vance RE , 'Critical function for Naip5 in inflammasome activation by a conserved carboxy-terminal domain of flagellin ' (2008 ) 9 Nat Immunol : 1171 -1178.

    • Search Google Scholar
  • Honko AN, Mizel SB: Effects of flagellin on innate and adaptive immunity. Immunol Res 33, 83–101 (2005)

    Mizel SB , 'Effects of flagellin on innate and adaptive immunity ' (2005 ) 33 Immunol Res : 83 -101.

    • Search Google Scholar
  • Crellin NK, Garcia RV, Hadisfar O, Allan SE, Steiner TS, Levings MK: Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells. J Immunol 175, 8051–8059 (2005)

    Levings MK , 'Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells ' (2005 ) 175 J Immunol : 8051 -8059.

    • Search Google Scholar
  • Hruz P, Eckmann L: Caspase recruitment domain-containing sensors and adaptors in intestinal innate immunity. Curr Opin Gastroenterol 24, 108–114 (2008)

    Eckmann L , 'Caspase recruitment domain-containing sensors and adaptors in intestinal innate immunity ' (2008 ) 24 Curr Opin Gastroenterol : 108 -114.

    • Search Google Scholar
  • Schmitt CK, Ikeda JS, Darnell SC, Watson PR, Bispham J, Wallis TS, Weinstein DL, Metcalf ES, O’Brien AD: Absence of all components of the flagellar export and synthesis machinery differentially alters virulence of Salmonella enterica serovar Typhimurium in models of typhoid fever, survival in macrophages, tissue culture invasiveness, and calf enterocolitis. Infect Immun 69, 5619–5625 (2001)

    O’Brien AD , 'Absence of all components of the flagellar export and synthesis machinery differentially alters virulence of Salmonella enterica serovar Typhimurium in models of typhoid fever, survival in macrophages, tissue culture invasiveness, and calf enterocolitis ' (2001 ) 69 Infect Immun : 5619 -5625.

    • Search Google Scholar
  • Hawn TR, Berrington WR, Smith IA, Uematsu S, Akira S, Aderem A, Smith KD, Skerrett SJ: Altered inflammatory responses in TLR5-deficient mice infected with Legionella pneumophila. J Immunol 179, 6981–6987 (2007)

    Skerrett SJ , 'Altered inflammatory responses in TLR5-deficient mice infected with Legionella pneumophila ' (2007 ) 179 J Immunol : 6981 -6987.

    • Search Google Scholar
  • Andersen-Nissen E, Hawn TR, Smith KD, Nachman A, Lampano AE, Uematsu S, Akira S, Aderem A: Cutting edge: Tlr5−/− mice are more susceptible to Escherichia coli urinary tract infection. J Immunol 178, 4717–4720 (2007)

    Aderem A , 'Cutting edge: Tlr5−/− mice are more susceptible to Escherichia coli urinary tract infection ' (2007 ) 178 J Immunol : 4717 -4720.

    • Search Google Scholar
  • Vijay-Kumar M, Wu H, Jones R, Grant G, Babbin B, King TP, Kelly D, Gewirtz AT, Neish AS: Flagellin suppresses epithelial apoptosis and limits disease during enteric infection. Am J Pathol 169, 1686–1700 (2006)

    Neish AS , 'Flagellin suppresses epithelial apoptosis and limits disease during enteric infection ' (2006 ) 169 Am J Pathol : 1686 -1700.

    • Search Google Scholar
  • Vijay-Kumar M, Aitken JD, Sanders CJ, Frias A, Sloane VM, Xu J, Neish AS, Rojas M, Gewirtz AT: Flagellin treatment protects against chemicals, bacteria, viruses, and radiation. J Immunol 180, 8280–8285 (2008)

    Gewirtz AT , 'Flagellin treatment protects against chemicals, bacteria, viruses, and radiation ' (2008 ) 180 J Immunol : 8280 -8285.

    • Search Google Scholar
  • Newton SM, Kotb M, Poirier TP, Stocker BA, Beachey EH: Expression and immunogenicity of a streptococcal M protein epitope inserted in Salmonella flagellin. Infect Immun 59, 2158–2165 (1991)

    Beachey EH , 'Expression and immunogenicity of a streptococcal M protein epitope inserted in Salmonella flagellin ' (1991 ) 59 Infect Immun : 2158 -2165.

    • Search Google Scholar
  • Cuadros C, Lopez-Hernandez FJ, Dominguez AL, McClelland M, Lustgarten J: Flagellin fusion proteins as adjuvants or vaccines induce specific immune responses. Infect Immun 72, 2810–2816 (2004)

    Lustgarten J , 'Flagellin fusion proteins as adjuvants or vaccines induce specific immune responses ' (2004 ) 72 Infect Immun : 2810 -2816.

    • Search Google Scholar
  • Honko AN, Sriranganathan N, Lees CJ, Mizel SB: Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis. Infect Immun 74, 1113–1120 (2006)

    Mizel SB , 'Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis ' (2006 ) 74 Infect Immun : 1113 -1120.

    • Search Google Scholar
  • Turley CB, Rupp RE, Johnson C, Taylor DN, Wolfson J, Tussey L, Kavita U, Stanberry L, Shaw A: Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults. Vaccine 29, 5145–5152 (2011)

    Shaw A , 'Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults ' (2011 ) 29 Vaccine : 5145 -5152.

    • Search Google Scholar
  • Song L, Zhang Y, Yun NE, Poussard AL, Smith JN, Smith JK, Borisevich V, Linde JJ, Zacks MA, Li H, Kavita U, Reiserova L, Liu X, Dumuren K, Balasubramanian B, Weaver B, Parent J, Umlauf S, Liu G, Huleatt J, Tussey L, Paessler S: Superior efficacy of a recombinant flagellin:H5N1 HA globular head vaccine is determined by the placement of the globular head within flagellin. Vaccine 27, 5875–5884 (2009)

    Paessler S , 'Superior efficacy of a recombinant flagellin:H5N1 HA globular head vaccine is determined by the placement of the globular head within flagellin ' (2009 ) 27 Vaccine : 5875 -5884.

    • Search Google Scholar
  • Camacho AG, Teixeira LH, Bargieri DY, Boscardin SB, Soares IS, Nussenzweig RS, Nussenzweig V, Rodrigues MM: TLR5-dependent immunogenicity of a recombinant fusion protein containing an immunodominant epitope of malarial circumsporozoite protein and the FliC flagellin of Salmonella typhimurium. Mem Inst Oswaldo Cruz 106 Suppl 1, 167–171 (2011)

    Rodrigues MM , 'TLR5-dependent immunogenicity of a recombinant fusion protein containing an immunodominant epitope of malarial circumsporozoite protein and the FliC flagellin of Salmonella typhimurium ' (2011 ) 106 Mem Inst Oswaldo Cruz : 167 -171.

    • Search Google Scholar
  • Tanomand A, Farajnia S, Najar Peerayeh S, Majidi J: Cloning, expression and characterization of recombinant exotoxin A-flagellin fusion protein as a new vaccine candidate against Pseudomonas aeruginosa infections. Iran Biomed J 17, 1–7 (2013)

    Majidi J , 'Cloning, expression and characterization of recombinant exotoxin A-flagellin fusion protein as a new vaccine candidate against Pseudomonas aeruginosa infections ' (2013 ) 17 Iran Biomed J : 1 -7.

    • Search Google Scholar
  • Treanor JJ, Taylor DN, Tussey L, Hay C, Nolan C, Fitzgerald T, Liu G, Kavita U, Song L, Dark I, Shaw A: Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults. Vaccine 28, 8268–8274 (2010)

    Shaw A , 'Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults ' (2010 ) 28 Vaccine : 8268 -8274.

    • Search Google Scholar
  • Ben-Yedidia T, Abel L, Arnon R, Globerson A: Efficacy of anti-influenza peptide vaccine in aged mice. Mech Ageing Dev 104, 11–23 (1998)

    Globerson A , 'Efficacy of anti-influenza peptide vaccine in aged mice ' (1998 ) 104 Mech Ageing Dev : 11 -23.

    • Search Google Scholar
  • Bates JT, Honko AN, Graff AH, Kock ND, Mizel SB: Mucosal adjuvant activity of flagellin in aged mice. Mech Ageing Dev 129, 271–281 (2008)

    Mizel SB , 'Mucosal adjuvant activity of flagellin in aged mice ' (2008 ) 129 Mech Ageing Dev : 271 -281.

    • Search Google Scholar
  • Asadi Karam MR, Oloomi M, Mahdavi M, Habibi M, Bouzari S: Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice. Vaccine 31, 1210–1216 (2013)

    Bouzari S , 'Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice ' (2013 ) 31 Vaccine : 1210 -1216.

    • Search Google Scholar
  • Sfondrini L, Rossini A, Besusso D, Merlo A, Tagliabue E, Menard S, Balsari A: Antitumor activity of the TLR-5 ligand flagellin in mouse models of cancer. J Immunol 176, 6624–6630 (2006)

    Balsari A , 'Antitumor activity of the TLR-5 ligand flagellin in mouse models of cancer ' (2006 ) 176 J Immunol : 6624 -6630.

    • Search Google Scholar
  • Rhee SH, Im E, Pothoulakis C: Toll-like receptor 5 engagement modulates tumor development and growth in a mouse xenograft model of human colon cancer. Gastroenterology 135, 518–528 (2008)

    Pothoulakis C , 'Toll-like receptor 5 engagement modulates tumor development and growth in a mouse xenograft model of human colon cancer ' (2008 ) 135 Gastroenterology : 518 -528.

    • Search Google Scholar
  • Cai Z, Sanchez A, Shi Z, Zhang T, Liu M, Zhang D: Activation of Toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth. Cancer Res 71, 2466–2475 (2011)

    Zhang D , 'Activation of Toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth ' (2011 ) 71 Cancer Res : 2466 -2475.

    • Search Google Scholar
  • Song EJ, Kang MJ, Kim YS, Kim SM, Lee SE, Kim CH, Kim DJ, Park JH: Flagellin promotes the proliferation of gastric cancer cells via the Toll-like receptor 5. Int J Mol Med 28, 115–119 (2011)

    Park JH , 'Flagellin promotes the proliferation of gastric cancer cells via the Toll-like receptor 5 ' (2011 ) 28 Int^J Mol Med : 115 -119.

    • Search Google Scholar
  • Lyons S, Wang L, Casanova JE, Sitaraman SV, Merlin D, Gewirtz AT: Salmonella typhimurium transcytoses flagellin via an SPI2-mediated vesicular transport pathway. J Cell Sci 117, 5771–5780 (2004)

    Gewirtz AT , 'Salmonella typhimurium transcytoses flagellin via an SPI2-mediated vesicular transport pathway ' (2004 ) 117 J Cell Sci : 5771 -5780.

    • Search Google Scholar
  • McCole DF: IBD candidate genes and intestinal barrier regulation. Inflamm Bowel Dis 20, 1829–1849 (2014)

    McCole DF , 'IBD candidate genes and intestinal barrier regulation ' (2014 ) 20 Inflamm Bowel Dis : 1829 -1849.

    • Search Google Scholar
  • Comalada M, Peppelenbosch MP: Impaired innate immunity in Crohn’s disease. Trends Mol Med 12, 397–399 (2006)

    Peppelenbosch MP , 'Impaired innate immunity in Crohn’s disease ' (2006 ) 12 Trends Mol Med : 397 -399.

    • Search Google Scholar
  • Lodes MJ, Cong Y, Elson CO, Mohamath R, Landers CJ, Targan SR, Fort M, Hershberg RM: Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest 113, 1296–1306 (2004)

    Hershberg RM , 'Bacterial flagellin is a dominant antigen in Crohn disease ' (2004 ) 113 J Clin Invest : 1296 -1306.

    • Search Google Scholar
  • Wallis D, Asaduzzaman A, Weisman M, Haroon N, Anton A, McGovern D, Targan S, Inman R: Elevated serum antiflagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: an observational study. Arthritis Res Ther 15, R166 (2013)

    Inman R , 'Elevated serum antiflagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: an observational study ' (2013 ) 15 Arthritis Res Ther : R166 -.

    • Search Google Scholar
  • Rhee SH, Im E, Riegler M, Kokkotou E, O’Brien M, Pothoulakis C: Pathophysiological role of Toll-like receptor 5 engagement by bacterial flagellin in colonic inflammation. Proc Natl Acad Sci U S A 102, 13610–13615 (2005)

    Pothoulakis C , 'Pathophysiological role of Toll-like receptor 5 engagement by bacterial flagellin in colonic inflammation ' (2005 ) 102 Proc Natl Acad Sci U S A : 13610 -13615.

    • Search Google Scholar
  • Gewirtz AT, Vijay-Kumar M, Brant SR, Duerr RH, Nicolae DL, Cho JH: Dominant-negative TLR5 polymorphism reduces adaptive immune response to flagellin and negatively associates with Crohn’s disease. Am J Physiol Gastrointest Liver Physiol 290, G1157–1163 (2006)

    Cho JH , 'Dominant-negative TLR5 polymorphism reduces adaptive immune response to flagellin and negatively associates with Crohn’s disease ' (2006 ) 290 Am J Physiol Gastrointest Liver Physiol : G1157 -1163.

    • Search Google Scholar
  • Schülke S, Burggraf M, Waibler Z, Wangorsch A, Wolfheimer S, Kalinke U, Vieths S, Toda M, Scheurer S: A fusion protein of flagellin and ovalbumin suppresses the TH2 response and prevents murine intestinal allergy. J Allergy Clin Immunol 128, 1340–1348, e12 (2011)

    Scheurer S , 'A fusion protein of flagellin and ovalbumin suppresses the TH2 response and prevents murine intestinal allergy ' (2011 ) 128 J Allergy Clin Immunol : 1340 -1348.

    • Search Google Scholar
  • Schulke S, Wolfheimer S, Gadermaier G, Wangorsch A, Siebeneicher S, Briza P, Spreitzer I, Schiller D, Loeschner B, Uematsu S, Ryffel B, Akira S, Waibler Z, Vieths S, Toda M, Scheurer S: Prevention of intestinal allergy in mice by rflaA:Ova is associated with enforced antigen processing and TLR5-dependent IL-10 secretion by mDC. PLoS One 9, e87822 (2014)

    Scheurer S , 'Prevention of intestinal allergy in mice by rflaA:Ova is associated with enforced antigen processing and TLR5-dependent IL-10 secretion by mDC ' (2014 ) 9 PLoS One : 87822 -.

    • Search Google Scholar
  • Wilson RH, Maruoka S, Whitehead GS, Foley JF, Flake GP, Sever ML, Zeldin DC, Kraft M, Garantziotis S, Nakano H, Cook DN: The Toll-like receptor 5 ligand flagellin promotes asthma by priming allergic responses to indoor allergens. Nat Med 18, 1705–1710 (2012)

    Cook DN , 'The Toll-like receptor 5 ligand flagellin promotes asthma by priming allergic responses to indoor allergens ' (2012 ) 18 Nat Med : 1705 -1710.

    • Search Google Scholar
  • Talbot HK, Rock MT, Johnson C, Tussey L, Kavita U, Shanker A, Shaw AR, Taylor DN: Immunopotentiation of trivalent influenza vaccine when given with VAX102, a recombinant influenza M2e vaccine fused to the TLR5 ligand flagellin. PLoS One 5, e14442 (2010)

    Taylor DN , 'Immunopotentiation of trivalent influenza vaccine when given with VAX102, a recombinant influenza M2e vaccine fused to the TLR5 ligand flagellin ' (2010 ) 5 PLoS One : 14442 -.

    • Search Google Scholar
  • Taylor DN, Treanor JJ, Sheldon EA, Johnson C, Umlauf S, Song L, Kavita U, Liu G, Tussey L, Ozer K, Hofstaetter T, Shaw A: Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response. Vaccine 30, 5761–5769 (2012)

    Shaw A , 'Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response ' (2012 ) 30 Vaccine : 5761 -5769.

    • Search Google Scholar
  • Gupta SK, Bajwa P, Deb R, Chellappa MM, Dey S: Flagellin a toll-like receptor 5 agonist as an adjuvant in chicken vaccines. Clin Vaccine Immunol 21, 261–270 (2014)

    Dey S , 'Flagellin a toll-like receptor 5 agonist as an adjuvant in chicken vaccines ' (2014 ) 21 Clin Vaccine Immunol : 261 -270.

    • Search Google Scholar
  • Ginsburg I: Role of lipoteichoic acid in infection and inflammation. Lancet Infect Dis 2, 171–179 (2002)

    Ginsburg I , 'Role of lipoteichoic acid in infection and inflammation ' (2002 ) 2 Lancet Infect Dis : 171 -179.

    • Search Google Scholar
  • Schneewind O, Missiakas D: Lipoteichoic acids, phosphate-containing polymers in the envelope of gram-positive bacteria. J Bacteriol 196, 1133–1142 (2014)

    Missiakas D , 'Lipoteichoic acids, phosphate-containing polymers in the envelope of gram-positive bacteria ' (2014 ) 196 J Bacteriol : 1133 -1142.

    • Search Google Scholar
  • Hermann C, Spreitzer I, Schroder NW, Morath S, Lehner MD, Fischer W, Schutt C, Schumann RR, Hartung T: Cytokine induction by purified lipoteichoic acids from various bacterial species–role of LBP, sCD14, CD14 and failure to induce IL-12 and subsequent IFN-gamma release. Eur J Immunol 32, 541–551 (2002)

    Hartung T , 'Cytokine induction by purified lipoteichoic acids from various bacterial species–role of LBP, sCD14, CD14 and failure to induce IL-12 and subsequent IFN-gamma release ' (2002 ) 32 Eur J Immunol : 541 -551.

    • Search Google Scholar
  • Otto M: MRSA virulence and spread. Cell Microbiol 14, 1513–1521 (2012)

    Otto M , 'MRSA virulence and spread ' (2012 ) 14 Cell Microbiol : 1513 -1521.

  • Kim H, Jung BJ, Kim JY, Chung DK: Differential effects of low and high doses of lipoteichoic acid on lipopolysaccharide-induced interleukin-6 production. Inflamm Res 63, 419–428 (2014)

    Chung DK , 'Differential effects of low and high doses of lipoteichoic acid on lipopolysaccharide-induced interleukin-6 production ' (2014 ) 63 Inflamm Res : 419 -428.

    • Search Google Scholar
  • Gao JJ, Xue Q, Zuvanich EG, Haghi KR, Morrison DC: Commercial preparations of lipoteichoic acid contain endotoxin that contributes to activation of mouse macrophages in vitro. Infect Immun 69, 751–757 (2001)

    Morrison DC , 'Commercial preparations of lipoteichoic acid contain endotoxin that contributes to activation of mouse macrophages in vitro ' (2001 ) 69 Infect Immun : 751 -757.

    • Search Google Scholar
  • Morath S, Geyer A, Hartung T: Structure–function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J Exp Med 193, 393–397 (2001)

    Hartung T , 'Structure–function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus ' (2001 ) 193 J Exp Med : 393 -397.

    • Search Google Scholar
  • Lysakova-Devine T, Keogh B, Harrington B, Nagpal K, Halle A, Golenbock DT, Monie T, Bowie AG: Viral inhibitory peptide of TLR4, a peptide derived from vaccinia protein A46, specifically inhibits TLR4 by directly targeting MyD88 adaptor-like and TRIF-related adaptor molecule. J Immunol 185, 4261–4271 (2010)

    Bowie AG , 'Viral inhibitory peptide of TLR4, a peptide derived from vaccinia protein A46, specifically inhibits TLR4 by directly targeting MyD88 adaptor-like and TRIF-related adaptor molecule ' (2010 ) 185 J Immunol : 4261 -4271.

    • Search Google Scholar
  • Seo HS, Michalek SM, Nahm MH: Lipoteichoic acid is important in innate immune responses to gram-positive bacteria. Infect Immun 76, 206–213 (2008)

    Nahm MH , 'Lipoteichoic acid is important in innate immune responses to gram-positive bacteria ' (2008 ) 76 Infect Immun : 206 -213.

    • Search Google Scholar
  • Sheen TR, Ebrahimi CM, Hiemstra IH, Barlow SB, Peschel A, Doran KS: Penetration of the blood–brain barrier by Staphylococcus aureus: contribution of membrane-anchored lipoteichoic acid. J Mol Med (Berl) 88, 633–639 (2010)

    Doran KS , 'Penetration of the blood–brain barrier by Staphylococcus aureus: contribution of membrane-anchored lipoteichoic acid ' (2010 ) 88 J Mol Med (Berl) : 633 -639.

    • Search Google Scholar
  • den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM: The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 54, 2325–2340 (2013)

    Bakker BM , 'The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism ' (2013 ) 54 J Lipid Res : 2325 -2340.

    • Search Google Scholar
  • Martinez I, Kim J, Duffy PR, Schlegel VL, Walter J: Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects. PLoS One 5, e15046 (2010)

    Walter J , 'Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects ' (2010 ) 5 PLoS One : 15046 -.

    • Search Google Scholar
  • Ramirez-Farias C, Slezak K, Fuller Z, Duncan A, Holtrop G, Louis P: Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr 101, 541–550 (2009)

    Louis P , 'Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii ' (2009 ) 101 Br J Nutr : 541 -550.

    • Search Google Scholar
  • Morrison DJ, Mackay WG, Edwards CA, Preston T, Dodson B, Weaver LT: Butyrate production from oligofructose fermentation by the human faecal flora: What is the contribution of extracellular acetate and lactate? Br J Nutr 96, 570–577 (2006)

    Weaver LT , 'Butyrate production from oligofructose fermentation by the human faecal flora: What is the contribution of extracellular acetate and lactate ' (2006 ) 96 Br J Nutr : 570 -577.

    • Search Google Scholar
  • Compendium of food additive specifications. Addendum 8. World Health Organization: Food and Agriculture Organization of the United Nations, Rome, 2000

    '', in Addendum 8. World Health Organization: Food and Agriculture Organization of the United Nations , (2000 ) -.

    • Search Google Scholar
  • Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ: Colonic health: Fermentation and short chain fatty acids. J Clin Gastroenterol 40, 235–243 (2006)

    Jenkins DJ , 'Colonic health: Fermentation and short chain fatty acids ' (2006 ) 40 J Clin Gastroenterol : 235 -243.

    • Search Google Scholar
  • Hold GL, Pryde SE, Russell VJ, Furrie E, Flint HJ: Assessment of microbial diversity in human colonic samples by 16S rDNA sequence analysis. FEMS Microbiol Ecol 39, 33–39 (2002)

    Flint HJ , 'Assessment of microbial diversity in human colonic samples by 16S rDNA sequence analysis ' (2002 ) 39 FEMS Microbiol Ecol : 33 -39.

    • Search Google Scholar
  • Bindels LB, Dewulf EM, Delzenne NM: GPR43/FFA2: physiopathological relevance and therapeutic prospects. Trends Pharmacol Sci 34, 226–232 (2013)

    Delzenne NM , 'GPR43/FFA2: physiopathological relevance and therapeutic prospects ' (2013 ) 34 Trends Pharmacol Sci : 226 -232.

    • Search Google Scholar
  • Inoue D, Tsujimoto G, Kimura I: Regulation of energy homeostasis by GPR41. Front Endocrinol (Lausanne) 5, 81 (2014)

    Kimura I , 'Regulation of energy homeostasis by GPR41 ' (2014 ) 5 Front Endocrinol (Lausanne) : 81 -.

    • Search Google Scholar
  • Daly K, Shirazi-Beechey SP: Microarray analysis of butyrate regulated genes in colonic epithelial cells. DNA Cell Biol 25, 49–62 (2006)

    Shirazi-Beechey SP , 'Microarray analysis of butyrate regulated genes in colonic epithelial cells ' (2006 ) 25 DNA Cell Biol : 49 -62.

    • Search Google Scholar
  • Lupton JR: Microbial degradation products influence colon cancer risk: The butyrate controversy. J Nutr 134, 479–482 (2004)

    Lupton JR , 'Microbial degradation products influence colon cancer risk: The butyrate controversy ' (2004 ) 134 J Nutr : 479 -482.

    • Search Google Scholar
  • Chen YX, Fang JY, Lu J, Qiu DK: Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines. Zhonghua Yi Xue Za Zhi 84, 312–317 (2004)

    Qiu DK , 'Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines ' (2004 ) 84 Zhonghua Yi Xue Za Zhi : 312 -317.

    • Search Google Scholar
  • Kim YS, Tsao D, Siddiqui B, Whitehead JS, Arnstein P, Bennett J, Hicks J: Effects of sodium butyrate and dimethylsulfoxide on biochemical properties of human colon cancer cells. Cancer 45, 1185–1192 (1980)

    Hicks J , 'Effects of sodium butyrate and dimethylsulfoxide on biochemical properties of human colon cancer cells ' (1980 ) 45 Cancer : 1185 -1192.

    • Search Google Scholar
  • Hague A, Manning AM, Hanlon KA, Huschtscha LI, Hart D, Paraskeva C: Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: Implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int J Cancer 55, 498–505 (1993)

    Paraskeva C , 'Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: Implications for the possible role of dietary fibre in the prevention of large-bowel cancer ' (1993 ) 55 Int J Cancer : 498 -505.

    • Search Google Scholar
  • Coradini D, Biffi A, Costa A, Pellizzaro C, Pirronello E, Di Fronzo G: Effect of sodium butyrate on human breast cancer cell lines. Cell Prolif 30, 149–159 (1997)

    Fronzo G , 'Effect of sodium butyrate on human breast cancer cell lines ' (1997 ) 30 Cell Prolif : 149 -159.

    • Search Google Scholar
  • Miyake H, Hara S, Arakawa S, Kamidono S, Hara I: Overexpression of Bcl-2 regulates sodium butyrate- and/or docetaxel-induced apoptosis in human bladder cancer cells both in vitro and in vivo. Int J Cancer 93, 26–32 (2001)

    Hara I , 'Overexpression of Bcl-2 regulates sodium butyrate- and/or docetaxel-induced apoptosis in human bladder cancer cells both in vitro and in vivo ' (2001 ) 93 Int J Cancer : 26 -32.

    • Search Google Scholar
  • Kuefer R, Hofer MD, Altug V, Zorn C, Genze F, Kunzi-Rapp K, Hautmann RE, Gschwend JE: Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer. Br J Cancer 90, 535–541 (2004)

    Gschwend JE , 'Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer ' (2004 ) 90 Br J Cancer : 535 -541.

    • Search Google Scholar
  • Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP: Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One 8, e70803 (2013)

    Ryan EP , 'Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults ' (2013 ) 8 PLoS One : 70803 -.

    • Search Google Scholar
  • Bordonaro M, Lazarova DL, Sartorelli AC: Butyrate and Wnt signaling: A possible solution to the puzzle of dietary fiber and colon cancer risk? Cell Cycle 7, 1178–1183 (2008)

    Sartorelli AC , 'Butyrate and Wnt signaling: A possible solution to the puzzle of dietary fiber and colon cancer risk ' (2008 ) 7 Cell Cycle : 1178 -1183.

    • Search Google Scholar
  • Hamer HM, Jonkers DM, Bast A, Vanhoutvin SA, Fischer MA, Kodde A, Troost FJ, Venema K, Brummer RJ: Butyrate modulates oxidative stress in the colonic mucosa of healthy humans. Clin Nutr 28, 88–93 (2009)

    Brummer RJ , 'Butyrate modulates oxidative stress in the colonic mucosa of healthy humans ' (2009 ) 28 Clin Nutr : 88 -93.

    • Search Google Scholar
  • Willemsen LE, Koetsier MA, van Deventer SJ, van Tol EA: Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts. Gut 52, 1442–1447 (2003)

    Tol EA , 'Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts ' (2003 ) 52 Gut : 1442 -1447.

    • Search Google Scholar
  • Canani RB, Costanzo MD, Leone L, Pedata M, Meli R, Calignano A: Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol 17, 1519–1528 (2011)

    Calignano A , 'Potential beneficial effects of butyrate in intestinal and extraintestinal diseases ' (2011 ) 17 World J Gastroenterol : 1519 -1528.

    • Search Google Scholar
  • Vernia P, Gnaedinger A, Hauck W, Breuer RI: Organic anions and the diarrhea of inflammatory bowel disease. Dig Dis Sci 33, 1353–1358 (1988)

    Breuer RI , 'Organic anions and the diarrhea of inflammatory bowel disease ' (1988 ) 33 Dig Dis Sci : 1353 -1358.

    • Search Google Scholar
  • Roediger WE: The colonic epithelium in ulcerative colitis: An energy-deficiency disease? Lancet 2, 712–715 (1980)

    Roediger WE , 'The colonic epithelium in ulcerative colitis: An energy-deficiency disease ' (1980 ) 2 Lancet : 712 -715.

    • Search Google Scholar
  • Scheppach W, Sommer H, Kirchner T, Paganelli GM, Bartram P, Christl S, Richter F, Dusel G, Kasper H: Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 103, 51–56 (1992)

    Kasper H , 'Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis ' (1992 ) 103 Gastroenterology : 51 -56.

    • Search Google Scholar
  • Butzner JD, Parmar R, Bell CJ, Dalal V: Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat. Gut 38, 568–573 (1996)

    Dalal V , 'Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat ' (1996 ) 38 Gut : 568 -573.

    • Search Google Scholar
  • Vieira EL, Leonel AJ, Sad AP, Beltrao NR, Costa TF, Ferreira TM, Gomes-Santos AC, Faria AM, Peluzio MC, Cara DC, Alvarez-Leite JI: Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis. J Nutr Biochem 23, 430–436 (2012)

    Alvarez-Leite JI , 'Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis ' (2012 ) 23 J Nutr Biochem : 430 -436.

    • Search Google Scholar
  • Venkatraman A, Ramakrishna BS, Shaji RV, Kumar NS, Pulimood A, Patra S: Amelioration of dextran sulfate colitis by butyrate: Role of heat shock protein 70 and NF-kappaB. Am J Physiol Gastrointest Liver Physiol 285, G177–184 (2003)

    Patra S , 'Amelioration of dextran sulfate colitis by butyrate: Role of heat shock protein 70 and NF-kappaB ' (2003 ) 285 Am J Physiol Gastrointest Liver Physiol : G177 -184.

    • Search Google Scholar
  • Atreya I, Atreya R, Neurath MF: NF-kappaB in inflammatory bowel disease. J Intern Med 263, 591–596 (2008)

    Neurath MF , 'NF-kappaB in inflammatory bowel disease ' (2008 ) 263 J Intern Med : 591 -596.

  • Scheppach W: Treatment of distal ulcerative colitis with short-chain fatty acid enemas. A placebo-controlled trial. German–Austrian SCFA Study Group. Dig Dis Sci 41, 2254–2259 (1996)

    Scheppach W , 'Treatment of distal ulcerative colitis with short-chain fatty acid enemas. A placebo-controlled trial. German–Austrian SCFA Study Group ' (1996 ) 41 Dig Dis Sci : 2254 -2259.

    • Search Google Scholar
  • Dover GJ, Brusilow S, Charache S: Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate. Blood 84, 339–343 (1994)

    Charache S , 'Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate ' (1994 ) 84 Blood : 339 -343.

    • Search Google Scholar
  • Collins AF, Pearson HA, Giardina P, McDonagh KT, Brusilow SW, Dover GJ: Oral sodium phenylbutyrate therapy in homozygous beta thalassemia: A clinical trial. Blood 85, 43–49 (1995)

    Dover GJ , 'Oral sodium phenylbutyrate therapy in homozygous beta thalassemia: A clinical trial ' (1995 ) 85 Blood : 43 -49.

    • Search Google Scholar
  • Patthamalai P, Fuchareon S, Chaneiam N, Ghalie RG, Chui DH, Boosalis MS, Perrine SP: A phase 2 trial of HQK-1001 in HbE-beta thalassemia demonstrates HbF induction and reduced anemia. Blood 123, 1956–1957 (2014)

    Perrine SP , 'A phase 2 trial of HQK-1001 in HbE-beta thalassemia demonstrates HbF induction and reduced anemia ' (2014 ) 123 Blood : 1956 -1957.

    • Search Google Scholar
  • Reid ME, El Beshlawy A, Inati A, Kutlar A, Abboud MR, Haynes J, Jr, Ward R, Sharon B, Taher AT, Smith W, Manwani D, Ghalie RG: A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease. Am J Hematol 89, 709–713 (2014)

    Ghalie RG , 'A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease ' (2014 ) 89 Am J Hematol : 709 -713.

    • Search Google Scholar
  • Burlina AB, Ogier H, Korall H, Trefz FK: Long-term treatment with sodium phenylbutyrate in ornithine transcarbamylase-deficient patients. Mol Genet Metab 72, 351–355 (2001)

    Trefz FK , 'Long-term treatment with sodium phenylbutyrate in ornithine transcarbamylase-deficient patients ' (2001 ) 72 Mol Genet Metab : 351 -355.

    • Search Google Scholar
  • Schroeder FA, Lin CL, Crusio WE, Akbarian S: Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatry 62, 55–64 (2007)

    Akbarian S , 'Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse ' (2007 ) 62 Biol Psychiatry : 55 -64.

    • Search Google Scholar
  • Ferrante RJ, Kubilus JK, Lee J, Ryu H, Beesen A, Zucker B, Smith K, Kowall NW, Ratan RR, Luthi-Carter R, Hersch SM: Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington’s disease mice. J Neurosci 23, 9418–9427 (2003)

    Hersch SM , 'Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington’s disease mice ' (2003 ) 23 J Neurosci : 9418 -9427.

    • Search Google Scholar
  • Kim HJ, Leeds P, Chuang DM: The HDAC inhibitor, sodium butyrate, stimulates neurogenesis in the ischemic brain. J Neurochem 110, 1226–1240 (2009)

    Chuang DM , 'The HDAC inhibitor, sodium butyrate, stimulates neurogenesis in the ischemic brain ' (2009 ) 110 J Neurochem : 1226 -1240.

    • Search Google Scholar
  • Wang L, Christophersen CT, Sorich MJ, Gerber JP, Angley MT, Conlon MA: Elevated fecal short chain fatty acid and ammonia concentrations in children with autism spectrum disorder. Dig Dis Sci 57, 2096–2102 (2012)

    Conlon MA , 'Elevated fecal short chain fatty acid and ammonia concentrations in children with autism spectrum disorder ' (2012 ) 57 Dig Dis Sci : 2096 -2102.

    • Search Google Scholar
  • Takuma K, Hara Y, Kataoka S, Kawanai T, Maeda Y, Watanabe R, Takano E, Hayata-Takano A, Hashimoto H, Ago Y, Matsuda T: Chronic treatment with valproic acid or sodium butyrate attenuates novel object recognition deficits and hippocampal dendritic spine loss in a mouse model of autism. Pharmacol Biochem Behav 126C, 43–49 (2014)

    Matsuda T , 'Chronic treatment with valproic acid or sodium butyrate attenuates novel object recognition deficits and hippocampal dendritic spine loss in a mouse model of autism ' (2014 ) 126C Pharmacol Biochem Behav : 43 -49.

    • Search Google Scholar
  • Bourdu S, Dapoigny M, Chapuy E, Artigue F, Vasson MP, Dechelotte P, Bommelaer G, Eschalier A, Ardid D: Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats. Gastroenterology 128, 1996–2008 (2005)

    Ardid D , 'Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats ' (2005 ) 128 Gastroenterology : 1996 -2008.

    • Search Google Scholar
  • Harris K, Kassis A, Major G, Chou CJ: Is the gut microbiota a new factor contributing to obesity and its metabolic disorders? J Obes 2012, 879151 (2012)

    Chou CJ , 'Is the gut microbiota a new factor contributing to obesity and its metabolic disorders ' (2012 ) 2012 J Obes : 879151 -.

    • Search Google Scholar
  • Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M, Cefalu WT, Ye J: Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58, 1509–1517 (2009)

    Ye J , 'Butyrate improves insulin sensitivity and increases energy expenditure in mice ' (2009 ) 58 Diabetes : 1509 -1517.

    • Search Google Scholar
  • Kamphuis MM, Lejeune MP, Saris WH, Westerterp-Plantenga MS: The effect of conjugated linoleic acid supplementation after weight loss on body weight regain, body composition, and resting metabolic rate in overweight subjects. Int J Obes Relat Metab Disord 27, 840–847 (2003)

    Westerterp-Plantenga MS , 'The effect of conjugated linoleic acid supplementation after weight loss on body weight regain, body composition, and resting metabolic rate in overweight subjects ' (2003 ) 27 Int J Obes Relat Metab Disord : 840 -847.

    • Search Google Scholar
  • Lecerf JM, Depeint F, Clerc E, Dugenet Y, Niamba CN, Rhazi L, Cayzeele A, Abdelnour G, Jaruga A, Younes H, Jacobs H, Lambrey G, Abdelnour AM, Pouillart PR: Xylooligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while XOS alone only shows prebiotic properties. Br J Nutr 108, 1847–1858 (2012)

    Pouillart PR , 'Xylooligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while XOS alone only shows prebiotic properties ' (2012 ) 108 Br J Nutr : 1847 -1858.

    • Search Google Scholar
  • Fernandes J, Su W, Rahat-Rozenbloom S, Wolever TM, Comelli EM: Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans. Nutr Diabetes 4, e121 (2014)

    Comelli EM , 'Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans ' (2014 ) 4 Nutr Diabetes : 121 -.

    • Search Google Scholar
  • Lin HV, Frassetto A, Kowalik EJ, Jr, Nawrocki AR, Lu MM, Kosinski JR, Hubert JA, Szeto D, Yao X, Forrest G, Marsh DJ: Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS One 7, e35240 (2012)

    Marsh DJ , 'Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms ' (2012 ) 7 PLoS One : 35240 -.

    • Search Google Scholar
  • Jakobsdottir G, Xu J, Molin G, Ahrne S, Nyman M: Highfat diet reduces the formation of butyrate, but increases succinate, inflammation, liver fat and cholesterol in rats, while dietary fibre counteracts these effects. PLoS One 8, e80476 (2013)

    Nyman M , 'Highfat diet reduces the formation of butyrate, but increases succinate, inflammation, liver fat and cholesterol in rats, while dietary fibre counteracts these effects ' (2013 ) 8 PLoS One : 80476 -.

    • Search Google Scholar
  • Li HP, Chen X, Li MQ: Butyrate alleviates metabolic impairments and protects pancreatic beta cell function in pregnant mice with obesity. Int J Clin Exp Pathol 6, 1574–1584 (2013)

    Li MQ , 'Butyrate alleviates metabolic impairments and protects pancreatic beta cell function in pregnant mice with obesity ' (2013 ) 6 Int J Clin Exp Pathol : 1574 -1584.

    • Search Google Scholar
  • Yadav H, Lee JH, Lloyd J, Walter P, Rane SG: Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. J Biol Chem 288, 25088–25097 (2013)

    Rane SG , 'Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion ' (2013 ) 288 J Biol Chem : 25088 -25097.

    • Search Google Scholar
  • Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D, Peng Y, Zhang D, Jie Z, Wu W, Qin Y, Xue W, Li J, Han L, Lu D, Wu P, Dai Y, Sun X, Li Z, Tang A, Zhong S, Li X, Chen W, Xu R, Wang M, Feng Q, Gong M, Yu J, Zhang Y, Zhang M, Hansen T, Sanchez G, Raes J, Falony G, Okuda S, Almeida M, LeChatelier E, Renault P, Pons N, Batto JM, Zhang Z, Chen H, Yang R, Zheng W, Li S, Yang H, Wang J, Ehrlich SD, Nielsen R, Pedersen O, Kristiansen K, Wang J: A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55–60 (2012)

    Wang J , 'A metagenome-wide association study of gut microbiota in type 2 diabetes ' (2012 ) 490 Nature : 55 -60.

    • Search Google Scholar
  • Assisi RF, GISDI Study Group: Combined butyric acid/mesalazine treatment in ulcerative colitis with mild-moderate activity. Results of a multicentre pilot study. Minerva Gastroenterol Dietol 54, 231–238 (2008)

    Assisi RF , 'Combined butyric acid/mesalazine treatment in ulcerative colitis with mild-moderate activity. Results of a multicentre pilot study ' (2008 ) 54 Minerva Gastroenterol Dietol : 231 -238.

    • Search Google Scholar
  • Steinhart AH, Brzezinski A, Baker JP: Treatment of refractory ulcerative proctosigmoiditis with butyrate enemas. Am J Gastroenterol 89, 179–183 (1994)

    Baker JP , 'Treatment of refractory ulcerative proctosigmoiditis with butyrate enemas ' (1994 ) 89 Am J Gastroenterol : 179 -183.

    • Search Google Scholar
  • Palou L, Usall J, Smilanick JL, Aguilar MJ, Vinas I: Evaluation of food additives and low-toxicity compounds as alternative chemicals for the control of Penicillium digitatum and Penicillium italicum on citrus fruit. Pest Manag Sci 58, 459–466 (2002)

    Vinas I , 'Evaluation of food additives and low-toxicity compounds as alternative chemicals for the control of Penicillium digitatum and Penicillium italicum on citrus fruit ' (2002 ) 58 Pest Manag Sci : 459 -466.

    • Search Google Scholar
  • Taniguchi M, Nakazawa H, Takeda O, Kaneko T, Hoshino K, Tanaka T: Production of a mixture of antimicrobial organic acids from lactose by co-culture of Bifidobacterium longum and Propionibacterium freudenreichii. Biosci Biotechnol Biochem 62, 1522–1527 (1998)

    Tanaka T , 'Production of a mixture of antimicrobial organic acids from lactose by co-culture of Bifidobacterium longum and Propionibacterium freudenreichii ' (1998 ) 62 Biosci Biotechnol Biochem : 1522 -1527.

    • Search Google Scholar
  • Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT: Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28, 1221–1227 (1987)

    Macfarlane GT , 'Short chain fatty acids in human large intestine, portal, hepatic and venous blood ' (1987 ) 28 Gut : 1221 -1227.

    • Search Google Scholar
  • Macy JM, Ljungdahl LG, Gottschalk G: Pathway of succinate and propionate formation in Bacteroides fragilis. J Bacteriol 134, 84–91 (1978)

    Gottschalk G , 'Pathway of succinate and propionate formation in Bacteroides fragilis ' (1978 ) 134 J Bacteriol : 84 -91.

    • Search Google Scholar
  • Hara T, Kashihara D, Ichimura A, Kimura I, Tsujimoto G, Hirasawa A: Role of free fatty acid receptors in the regulation of energy metabolism. Biochim Biophys Acta 1841, 1292–1300 (2014)

    Hirasawa A , 'Role of free fatty acid receptors in the regulation of energy metabolism ' (2014 ) 1841 Biochim Biophys Acta : 1292 -1300.

    • Search Google Scholar
  • Bergman EN: Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiol Rev 70, 567–590 (1990)

    Bergman EN , 'Energy contributions of volatile fatty acids from the gastrointestinal tract in various species ' (1990 ) 70 Physiol Rev : 567 -590.

    • Search Google Scholar
  • Demigne C, Morand C, Levrat MA, Besson C, Moundras C, Remesy C: Effect of propionate on fatty acid and cholesterol synthesis and on acetate metabolism in isolated rat hepatocytes. Br J Nutr 74, 209–219 (1995)

    Remesy C , 'Effect of propionate on fatty acid and cholesterol synthesis and on acetate metabolism in isolated rat hepatocytes ' (1995 ) 74 Br J Nutr : 209 -219.

    • Search Google Scholar
  • Lin Y, Vonk RJ, Slooff MJ, Kuipers F, Smit MJ: Differences in propionate-induced inhibition of cholesterol and triacylglycerol synthesis between human and rat hepatocytes in primary culture. Br J Nutr 74, 197–207 (1995)

    Smit MJ , 'Differences in propionate-induced inhibition of cholesterol and triacylglycerol synthesis between human and rat hepatocytes in primary culture ' (1995 ) 74 Br J Nutr : 197 -207.

    • Search Google Scholar
  • Xiong Y, Miyamoto N, Shibata K, Valasek MA, Motoike T, Kedzierski RM, Yanagisawa M: Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proc Natl Acad Sci U S A 101, 1045–1050 (2004)

    Yanagisawa M , 'Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41 ' (2004 ) 101 Proc Natl Acad Sci U S A : 1045 -1050.

    • Search Google Scholar
  • Al-Lahham SH, Roelofsen H, Priebe M, Weening D, Dijkstra M, Hoek A, Rezaee F, Venema K, Vonk RJ: Regulation of adipokine production in human adipose tissue by propionic acid. Eur J Clin Invest 40, 401–407 (2010)

    Vonk RJ , 'Regulation of adipokine production in human adipose tissue by propionic acid ' (2010 ) 40 Eur J Clin Invest : 401 -407.

    • Search Google Scholar
  • Ge H, Li X, Weiszmann J, Wang P, Baribault H, Chen JL, Tian H, Li Y: Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. Endocrinology 149, 4519–4526 (2008)

    Li Y , 'Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids ' (2008 ) 149 Endocrinology : 4519 -4526.

    • Search Google Scholar
  • Psichas A, Sleeth ML, Murphy KG, Brooks L, Bewick GA, Hanyaloglu AC, Ghatei MA, Bloom SR, Frost G: The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents. Int J Obes (Lond) (2014)

    Frost G , '', in Int J Obes (Lond) , (2014 ) -.

  • Todesco T, Rao AV, Bosello O, Jenkins DJ: Propionate lowers blood glucose and alters lipid metabolism in healthy subjects. Am J Clin Nutr 54, 860–865 (1991)

    Jenkins DJ , 'Propionate lowers blood glucose and alters lipid metabolism in healthy subjects ' (1991 ) 54 Am J Clin Nutr : 860 -865.

    • Search Google Scholar
  • Liljeberg HG, Lonner CH, Bjorck IM: Sourdough fermentation or addition of organic acids or corresponding salts to bread improves nutritional properties of starch in healthy humans. J Nutr 125, 1503–1511 (1995)

    Bjorck IM , 'Sourdough fermentation or addition of organic acids or corresponding salts to bread improves nutritional properties of starch in healthy humans ' (1995 ) 125 J Nutr : 1503 -1511.

    • Search Google Scholar
  • Anderson JW, Chen WJ: Plant fiber. Carbohydrate and lipid metabolism. Am J Clin Nutr 32, 346–363 (1979)

    Chen WJ , 'Plant fiber. Carbohydrate and lipid metabolism ' (1979 ) 32 Am J Clin Nutr : 346 -363.

    • Search Google Scholar
  • Robertson MD, Bickerton AS, Dennis AL, Vidal H, Frayn KN: Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. Am J Clin Nutr 82, 559–567 (2005)

    Frayn KN , 'Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism ' (2005 ) 82 Am J Clin Nutr : 559 -567.

    • Search Google Scholar
  • Robertson MD, Wright JW, Loizon E, Debard C, Vidal H, Shojaee-Moradie F, Russell-Jones D, Umpleby AM: Insulin-sensitizing effects on muscle and adipose tissue after dietary fiber intake in men and women with metabolic syndrome. J Clin Endocrinol Metab 97, 3326–3332 (2012)

    Umpleby AM , 'Insulin-sensitizing effects on muscle and adipose tissue after dietary fiber intake in men and women with metabolic syndrome ' (2012 ) 97 J Clin Endocrinol Metab : 3326 -3332.

    • Search Google Scholar
  • Bodinham CL, Smith L, Thomas EL, Bell JD, Swann JR, Costabile A, Russell-Jones D, Umpleby AM, Robertson MD: Efficacy of increased resistant starch consumption in human type 2 diabetes. Endocr Connect 3, 75–84 (2014)

    Robertson MD , 'Efficacy of increased resistant starch consumption in human type 2 diabetes ' (2014 ) 3 Endocr Connect : 75 -84.

    • Search Google Scholar
  • Cox AJ, West NP, Cripps AW: Obesity, inflammation, and the gut microbiota. Lancet Diabetes Endocrinol (2014)

    Cripps AW , '', in Lancet Diabetes Endocrinol , (2014 ) -.

  • Wajner M, Santos KD, Schlottfeldt JL, Rocha MP, Wannmacher CM: Inhibition of mitogen-activated proliferation of human peripheral lymphocytes in vitro by propionic acid. Clin Sci (Lond) 96, 99–103 (1999)

    Wannmacher CM , 'Inhibition of mitogen-activated proliferation of human peripheral lymphocytes in vitro by propionic acid ' (1999 ) 96 Clin Sci (Lond) : 99 -103.

    • Search Google Scholar
  • Senagore AJ, MacKeigan JM, Scheider M, Ebrom JS: Short-chain fatty acid enemas: A cost-effective alternative in the treatment of nonspecific proctosigmoiditis. Dis Colon Rectum 35, 923–927 (1992)

    Ebrom JS , 'Short-chain fatty acid enemas: A cost-effective alternative in the treatment of nonspecific proctosigmoiditis ' (1992 ) 35 Dis Colon Rectum : 923 -927.

    • Search Google Scholar
  • Vernia P, Marcheggiano A, Caprilli R, Frieri G, Corrao G, Valpiani D, Di Paolo MC, Paoluzi P, Torsoli A: Short-chain fatty acid topical treatment in distal ulcerative colitis. Aliment Pharmacol Ther 9, 309–313 (1995)

    Torsoli A , 'Short-chain fatty acid topical treatment in distal ulcerative colitis ' (1995 ) 9 Aliment Pharmacol Ther : 309 -313.

    • Search Google Scholar
  • Breuer RI, Soergel KH, Lashner BA, Christ ML, Hanauer SB, Vanagunas A, Harig JM, Keshavarzian A, Robinson M, Sellin JH, Weinberg D, Vidican DE, Flemal KL, Rademaker AW: Short chain fatty acid rectal irrigation for leftsided ulcerative colitis: A randomised, placebo controlled trial. Gut 40, 485–491 (1997)

    Rademaker AW , 'Short chain fatty acid rectal irrigation for leftsided ulcerative colitis: A randomised, placebo controlled trial ' (1997 ) 40 Gut : 485 -491.

    • Search Google Scholar
  • Tana C, Umesaki Y, Imaoka A, Handa T, Kanazawa M, Fukudo S: Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil 22, 512–519, e114–115 (2010)

    Fukudo S , 'Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome ' (2010 ) 22 Neurogastroenterol Motil : e114 -115.

    • Search Google Scholar
  • Scheppach W, Bartram HP, Richter F: Role of short-chain fatty acids in the prevention of colorectal cancer. Eur J Cancer 31A, 1077–1080 (1995)

    Richter F , 'Role of short-chain fatty acids in the prevention of colorectal cancer ' (1995 ) 31A Eur J Cancer : 1077 -1080.

    • Search Google Scholar
  • Hague A, Elder DJ, Hicks DJ, Paraskeva C: Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int J Cancer 60, 400–406 (1995)

    Paraskeva C , 'Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate ' (1995 ) 60 Int J Cancer : 400 -406.

    • Search Google Scholar
  • Jan G, Belzacq AS, Haouzi D, Rouault A, Metivier D, Kroemer G, Brenner C: Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria. Cell Death Differ 9, 179–188 (2002)

    Brenner C , 'Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria ' (2002 ) 9 Cell Death Differ : 179 -188.

    • Search Google Scholar
  • Hinnebusch BF, Meng S, Wu JT, Archer SY, Hodin RA: The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J Nutr 132, 1012–1017 (2002)

    Hodin RA , 'The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation ' (2002 ) 132 J Nutr : 1012 -1017.

    • Search Google Scholar
  • Ando T, Rasmussen K, Nyhan WL, Donnell GN, Barnes ND: Propionic acidemia in patients with ketotic hyperglycinemia. J Pediatr 78, 827–832 (1971)

    Barnes ND , 'Propionic acidemia in patients with ketotic hyperglycinemia ' (1971 ) 78 J Pediatr : 827 -832.

    • Search Google Scholar
  • Hsia YE, Scully KJ, Rosenberg LE: Inherited propionyl-Coa carboxylase deficiency in “ketotic hyperglycinemia.” J Clin Invest 50, 127–130 (1971)

    Rosenberg LE , 'Inherited propionyl-Coa carboxylase deficiency in “ketotic hyperglycinemia.” ' (1971 ) 50 J Clin Invest : 127 -130.

    • Search Google Scholar
  • Henriquez H, el Din A, Ozand PT, Subramanyam SB, al Gain SI: Emergency presentations of patients with methylmalonic acidemia, propionic acidemia and branched chain amino acidemia (MSUD). Brain Dev 16 Suppl, 86–93 (1994)

    Gain SI , 'Emergency presentations of patients with methylmalonic acidemia, propionic acidemia and branched chain amino acidemia (MSUD) ' (1994 ) 16 Brain Dev : 86 -93.

    • Search Google Scholar
  • Yorifuji T, Muroi J, Uematsu A, Nakahata T, Egawa H, Tanaka K: Living-related liver transplantation for neonatal-onset propionic acidemia. J Pediatr 137, 572–574 (2000)

    Tanaka K , 'Living-related liver transplantation for neonatal-onset propionic acidemia ' (2000 ) 137 J Pediatr : 572 -574.

    • Search Google Scholar
  • MacFabe DF, Cain DP, Rodriguez-Capote K, Franklin AE, Hoffman JE, Boon F, Taylor AR, Kavaliers M, Ossenkopp KP: Neurobiological effects of intraventricular propionic acid in rats: Possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav Brain Res 176, 149–169 (2007)

    Ossenkopp KP , 'Neurobiological effects of intraventricular propionic acid in rats: Possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders ' (2007 ) 176 Behav Brain Res : 149 -169.

    • Search Google Scholar
  • Shultz SR, MacFabe DF, Ossenkopp KP, Scratch S, Whelan J, Taylor R, Cain DP: Intracerebroventricular injection of propionic acid, an enteric bacterial metabolic end-product, impairs social behavior in the rat: Implications for an animal model of autism. Neuropharmacology 54, 901–911 (2008)

    Cain DP , 'Intracerebroventricular injection of propionic acid, an enteric bacterial metabolic end-product, impairs social behavior in the rat: Implications for an animal model of autism ' (2008 ) 54 Neuropharmacology : 901 -911.

    • Search Google Scholar
  • Shultz SR, Macfabe DF, Martin S, Jackson J, Taylor R, Boon F, Ossenkopp KP, Cain DP: Intracerebroventricular injections of the enteric bacterial metabolic product propionic acid impair cognition and sensorimotor ability in the Long-Evans rat: further development of a rodent model of autism. Behav Brain Res 200, 33–41 (2009)

    Cain DP , 'Intracerebroventricular injections of the enteric bacterial metabolic product propionic acid impair cognition and sensorimotor ability in the Long-Evans rat: further development of a rodent model of autism ' (2009 ) 200 Behav Brain Res : 33 -41.

    • Search Google Scholar
  • Thomas RH, Foley KA, Mepham JR, Tichenoff LJ, Possmayer F, MacFabe DF: Altered brain phospholipid and acylcarnitine profiles in propionic acid infused rodents: Further development of a potential model of autism spectrum disorders. J Neurochem 113, 515–529 (2010)

    MacFabe DF , 'Altered brain phospholipid and acylcarnitine profiles in propionic acid infused rodents: Further development of a potential model of autism spectrum disorders ' (2010 ) 113 J Neurochem : 515 -529.

    • Search Google Scholar
  • Brusque AM, Mello CF, Buchanan DN, Terracciano ST, Rocha MP, Vargas CR, Wannmacher CM, Wajner M: Effect of chemically induced propionic acidemia on neurobehavioral development of rats. Pharmacol Biochem Behav 64, 529–534 (1999)

    Wajner M , 'Effect of chemically induced propionic acidemia on neurobehavioral development of rats ' (1999 ) 64 Pharmacol Biochem Behav : 529 -534.

    • Search Google Scholar
  • Niederman R, Buyle-Bodin Y, Lu BY, Robinson P, Naleway C: Short-chain carboxylic acid concentration in human gingival crevicular fluid. J Dent Res 76, 575–579 (1997)

    Naleway C , 'Short-chain carboxylic acid concentration in human gingival crevicular fluid ' (1997 ) 76 J Dent Res : 575 -579.

    • Search Google Scholar
  • Kashket S, Zhang J, Niederman R: Gingival inflammation induced by food and short-chain carboxylic acids. J Dent Res 77, 412–417 (1998)

    Niederman R , 'Gingival inflammation induced by food and short-chain carboxylic acids ' (1998 ) 77 J Dent Res : 412 -417.

    • Search Google Scholar
  • Jacobi CA, Malfertheiner P: Escherichia coli Nissle 1917 (Mutaflor): New insights into an old probiotic bacterium. Dig Dis 29, 600–607 (2011)

    Malfertheiner P , 'Escherichia coli Nissle 1917 (Mutaflor): New insights into an old probiotic bacterium ' (2011 ) 29 Dig Dis : 600 -607.

    • Search Google Scholar
  • Mayerhofer F, Petuely F: Untersuchungen zur Regulation der Darmtätigkeit des Erwachsenen mit Hilfe der Lactulose (Bifidus-Faktor). Wiener Wschr 71, 865–869 (1959)

    Petuely F , 'Untersuchungen zur Regulation der Darmtätigkeit des Erwachsenen mit Hilfe der Lactulose (Bifidus-Faktor) ' (1959 ) 71 Wiener Wschr : 865 -869.

    • Search Google Scholar

The author instruction is available in PDF.
Please, download the file from HERE.

 

MANUSCRIPT SUBMISSION

Language: English

Founded in 2011
Publication: One volume of four issues annually

Publication Programme: 2020. Vol. 10. (Online Only)

Article Processing Charge: EUR 600.00 (for discounts see the Open Access menu)

Indexing and Abstracting Services:

  • PubMed Central
  • ESCI

Senior editors

Editor(s)-in-Chief: Dunay, Ildiko Rita

Editor(s)-in-Chief: Heimesaat, Markus M.

Vice Editor(s)-in-Chief: Fuchs, Anja

Editorial Board

Chair of the Editorial Board:
Jeffrey S. Buguliskis (Thomas Jefferson University, USA)

  • Jörn Albring (University of Münster, Germany)
  • Stefan Bereswill (Charité - University Medicine Berlin, Germany)
  • Dunja Bruder (University of Megdeburg, Germany)
  • Jan Buer (University of Duisburg, Germany)
  • Jeff Buguliskis (Thomas Jefferson University, USA)
  • Edit Buzas (Semmelweis University, Hungary)
  • Charles Collyer (University of Sydney, Australia)
  • Renato Damatta (UENF, Brazil)
  • Ivelina Damjanova (Semmelweis University, Hungary)
  • Maria Deli (Biological Research Center, HAS, Hungary)
  • Olgica Djurković-Djaković (University of Belgrade, Serbia)
  • Jean-Dennis Docquier (University of Siena, Italy)
  • Anna Erdei (Eötvös Loránd University, Hungary)
  • Zsuzsanna Fabry (University of Washington, USA)
  • Beniam Ghebremedhin (Witten/Herdecke University, Germany)
  • Nancy Guillen (Institute Pasteur, France)
  • Georgina L. Hold (University of Aberdeen, United Kingdom)
  • Ralf Ignatius (Charité - University Medicine Berlin, Germany)
  • Zsuzsanna Izsvak (MDC-Berlin, Germany)
  • Achim Kaasch (University of Cologne, Germany)
  • Tamás Laskay (University of Lübeck, Germany)
  • Oliver Liesenfeld (Roche, USA)
  • Shreemanta Parida (Vaccine Grand Challenge Program, India)
  • Matyas Sandor (University of Wisconsin, USA)
  • Ulrich Steinhoff (University of Marburg, Germany)
  • Michal Toborek (University of Miami, USA)
  • Mary Jo Wick (University of Gothenburg, Sweden)
  • Susanne A. Wolf (MDC-Berlin, Germany)

 

Dr. Dunay, Ildiko Rita
Magdeburg, Germany
E-mail: ildikodunay@gmail.com
You can find more information at http://eujmi.com